Adjuvant high-dose-rate interstitial brachytherapy for malignant peripheral nerve sheath tumor of the foot: a case report.
MPNST
foot soft tissue sarcoma
interstitial HDR brachytherapy
lower extremity
Journal
Journal of contemporary brachytherapy
ISSN: 1689-832X
Titre abrégé: J Contemp Brachytherapy
Pays: Poland
ID NLM: 101506276
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
03
07
2020
accepted:
20
03
2021
entrez:
14
6
2021
pubmed:
15
6
2021
medline:
15
6
2021
Statut:
ppublish
Résumé
Soft tissue sarcomas of the foot are extremely rare and can therefore be misdiagnosed as benign diseases, and be prematurely removed with an unplanned excision. The standard treatment is a wide local excision with an addition of radiotherapy as an alternative to a radical resection (e.g., below-knee or foot amputation). We report on a patient with primary malignant peripheral nerve sheath tumor in the foot plantar soft tissue, who had no evidence of the disease and no severe late toxicity higher than grade 2, 40 months after receiving amputation of toes and adjuvant interstitial high-dose-rate brachytherapy (HDR-BT). To the best of our knowledge, only a few cases were treated with HDR-BT with this scenario. From our findings, HDR-BT could be a safe and quick treatment option for these types of lesions.
Identifiants
pubmed: 34122575
doi: 10.5114/jcb.2021.106204
pii: 44100
pmc: PMC8170520
doi:
Types de publication
Case Reports
Langues
eng
Pagination
338-346Informations de copyright
Copyright © 2021 Termedia.
Déclaration de conflit d'intérêts
The authors report no conflict of interest.
Références
World J Surg Oncol. 2006 Aug 22;4:55
pubmed: 16923196
J Clin Oncol. 1998 Jan;16(1):197-203
pubmed: 9440743
Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):351-60
pubmed: 9788415
Can J Surg. 2010 Dec;53(6):424-31
pubmed: 21092437
Chin Clin Oncol. 2018 Aug;7(4):41
pubmed: 29860849
Brachytherapy. 2013 May-Jun;12(3):179-90
pubmed: 23434220
Strahlenther Onkol. 2010 Apr;186(4):224-8
pubmed: 20354665
J Contemp Brachytherapy. 2020 Feb;12(1):84-89
pubmed: 32190074
Clin Imaging. 2020 May;61:90-94
pubmed: 32000118
Int J Surg Oncol. 2016;2016:5963167
pubmed: 27803813
J Clin Oncol. 1996 Mar;14(3):859-68
pubmed: 8622034
J Natl Compr Canc Netw. 2016 Jun;14(6):758-86
pubmed: 27283169
Foot Ankle Int. 2008 Jul;29(7):690-8
pubmed: 18785419
J Contemp Brachytherapy. 2020 Aug;12(4):397-404
pubmed: 33293980
J Foot Ankle Surg. 2017 Jan - Feb;56(1):129-134
pubmed: 27449524
Brachytherapy. 2017 May - Jun;16(3):466-489
pubmed: 28342738
Foot Ankle Spec. 2017 Feb;10(1):12-19
pubmed: 27587379
EFORT Open Rev. 2017 Oct 17;2(10):421-431
pubmed: 29209518
Anticancer Res. 2020 Apr;40(4):1817-1831
pubmed: 32234870
Cancer. 2006 Sep 1;107(5):1065-74
pubmed: 16881077
J Contemp Brachytherapy. 2015 Oct;7(5):327-35
pubmed: 26622237
Ann Surg Oncol. 2012 Mar;19(3):878-85
pubmed: 21861229
Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1112-6
pubmed: 12829149
Clin Orthop Relat Res. 2010 Nov;468(11):3028-34
pubmed: 20496020
Front Surg. 2016 Mar 08;3:15
pubmed: 27014697
Front Oncol. 2014 Nov 17;4:324
pubmed: 25452937
Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1341-6
pubmed: 7713792
Eur J Cancer. 2016 Mar;56:77-84
pubmed: 26824706
Anticancer Res. 2016 Sep;36(9):4825-31
pubmed: 27630336
Cancers (Basel). 2020 Aug 12;12(8):
pubmed: 32806601
Am J Clin Oncol. 2018 May;41(5):465-470
pubmed: 27281262
Musculoskelet Surg. 2017 Dec;101(3):243-248
pubmed: 28444540
Br J Dermatol. 2005 Jul;153(1):79-82
pubmed: 16029330
EFORT Open Rev. 2017 May 11;2(5):261-271
pubmed: 28630763
World J Surg Oncol. 2011 Dec 05;9:160
pubmed: 22142486
Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):259-65
pubmed: 8407399
Acta Radiol Short Rep. 2014 Jan 14;3(1):2047981613516033
pubmed: 24778799
Brachytherapy. 2012 Sep-Oct;11(5):392-7
pubmed: 22436515
World J Clin Oncol. 2020 Apr 24;11(4):180-189
pubmed: 32355640
J Bone Joint Surg Am. 2015 Apr 1;97(7):597-603
pubmed: 25834085
Sarcoma. 1999;3(1):17-24
pubmed: 18521260
Indian J Med Paediatr Oncol. 2017 Apr-Jun;38(2):232-235
pubmed: 28900340